Skip to main content
Journal cover image

Extended Treatment-dose Antibiotic Therapy vs Low-dose Prophylaxis for the Management of Recurrent Uncomplicated Urinary Tract Infections in Peri- and Post-menopausal Women.

Publication ,  Journal Article
Luchristt, D; Siddiqui, NY; Bruton, Y; Visco, AG
Published in: Urology
April 2025

OBJECTIVE: To assess treatment efficacy over 1year in women with recurrent urinary tract infection (UTI) receiving extended treatment-strength antibiotics compared to standard low-dose prophylactic antibiotic regimens. METHODS: A retrospective cohort study of adult women presenting with acute uncomplicated UTI between January 1, 2018 and October 1, 2020 meeting recurrent UTI criteria (≥2 in 6months or ≥3 in 1year). Women were offered either: (1) treatment-strength antibiotic therapy for 1month; or (2) up to 7days of treatment-strength antibiotics followed by ≥3-month of low-dose prophylactic antibiotics. We excluded those with complicated UTI. The primary outcome was one or more symptomatic, culture-proven UTIs within 12months. Multivariable logistic regression assessed differences in the primary outcome while controlling for potential confounders. RESULTS: Among the 246 patients, women receiving extended treatment dose antibiotics (n=43) had a significantly lower risk of experiencing subsequent UTI within 1year when compared to those receiving standard prophylactic dosing for ≥3-month (n=203) (rate 34.9% vs 59.6%; P<.01). This significant risk reduction was maintained in logistic regression analyses while controlling for potentially confounding variables (aOR 0.42; 95% CI 0.20, 0.89). CONCLUSION: Women treated with a 1-month course of treatment-strength antibiotics had a significantly lower risk of subsequent UTI within 12months compared to women receiving ≥3-month of prophylactic antibiotics. These retrospective data preliminarily suggest that extended treatment-strength antibiotic dosing may provide therapeutic benefit while reducing overall cumulative antibiotic dose and duration. This innovative approach warrants further evaluation in randomized trials.

Duke Scholars

Published In

Urology

DOI

EISSN

1527-9995

Publication Date

April 2025

Volume

198

Start / End Page

29 / 35

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Urinary Tract Infections
  • Treatment Outcome
  • Time Factors
  • Secondary Prevention
  • Retrospective Studies
  • Recurrence
  • Postmenopause
  • Middle Aged
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Luchristt, D., Siddiqui, N. Y., Bruton, Y., & Visco, A. G. (2025). Extended Treatment-dose Antibiotic Therapy vs Low-dose Prophylaxis for the Management of Recurrent Uncomplicated Urinary Tract Infections in Peri- and Post-menopausal Women. Urology, 198, 29–35. https://doi.org/10.1016/j.urology.2024.12.029
Luchristt, Douglas, Nazema Y. Siddiqui, Yasmeen Bruton, and Anthony G. Visco. “Extended Treatment-dose Antibiotic Therapy vs Low-dose Prophylaxis for the Management of Recurrent Uncomplicated Urinary Tract Infections in Peri- and Post-menopausal Women.Urology 198 (April 2025): 29–35. https://doi.org/10.1016/j.urology.2024.12.029.
Luchristt, Douglas, et al. “Extended Treatment-dose Antibiotic Therapy vs Low-dose Prophylaxis for the Management of Recurrent Uncomplicated Urinary Tract Infections in Peri- and Post-menopausal Women.Urology, vol. 198, Apr. 2025, pp. 29–35. Pubmed, doi:10.1016/j.urology.2024.12.029.
Journal cover image

Published In

Urology

DOI

EISSN

1527-9995

Publication Date

April 2025

Volume

198

Start / End Page

29 / 35

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Urinary Tract Infections
  • Treatment Outcome
  • Time Factors
  • Secondary Prevention
  • Retrospective Studies
  • Recurrence
  • Postmenopause
  • Middle Aged
  • Humans